Vertiv VRT Expands Power Protection Portfolio with Launch of PowerUPS 100 Standby Series in North America Warren Buffett Teases Tiny Purchase in March Berkshire Filing May Identify the Investment SpaceX OpenAI FirstDay Trading Valuations Could Surpass Berkshire Hathaway Polymarket Traders Suggest Fed Minutes Reveal Potential Rate Hikes if Inflation Persists Amid Geopolitical Tensions PepsiCo Reportedly Plans Snack Price Hikes in Late June Bloomberg Indicates Morgan Stanley Lowers MGE Energy Price Target Amid Utility Sector Weakness ELLO Q3 2024 Earnings Solid Earnings Amid Quiet Quarter Stock Dips Slightly RBC Bearings Q1 2026 Earnings EPS Surpasses Expectations by Nearly 8 LFT Q1 2026 Earnings EPS Miss Weighs on Market Sentiment ROG Q1 2026 Earnings EPS Surpasses Estimates as Stock Gains DBRG Q1 2026 Earnings EPS Misses Estimates Amid Mixed Market Response ACTU Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Phase Foremost Clean Energy FMST Pushes Higher Testing Key Resistance Zone Marvell Technology Gains Momentum MRVL Approaches Key Resistance After 29 Rally Coherus Oncology Inc CHRS Rises 255 Key Levels to Watch After Support Hold Comstock Inc LODE Surges Nearly 5 as Bullish Momentum Builds SOS Limited SOS Holds Steady at 108 as Key Support and Resistance Levels Remain in Play Corpay Inc Q1 2026 Earnings EPS Beat Drives Modest Stock Gain FFAI Q1 2026 Earnings Narrowed Losses Beat Estimates but No Revenue Reported and Stock Drops 981 SEER Q1 2026 Earnings Narrowly Beats EPS Estimates as Company Maintains Cost Discipline HSBC Q1 2026 Earnings Modest EPS Beat Amid Stable Performance TSAT Q1 2026 Earnings Significant EPS Miss as Revenue Details Remain Unavailable WDS Q4 2025 Earnings Strong EPS Beat Amid Operational Strength AI Technology Divides Filmmakers at Cannes Market Implications for Entertainment Sector MARPS Q4 2025 Earnings Royalty Income Holds Steady Amid No Revenue Expectation Celanese CE Slips 096 as Chemical Sector Faces Persistent Headwinds WEBTOON Entertainment WBTN Q1 2026 Earnings EPS Beat Driven by Cost Controls Amid Revenue Uncertainty PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response DTIL Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Advances Pipeline MPLX Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds ARDX Q1 2026 Earnings EPS Misses Estimates by 142 Revenue Not Disclosed BJRI Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher DFLI Q1 2026 Earnings EPS Misses Estimates Despite Stock Gain